GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Verano Holdings Corp (OTCPK:VRNOF) » Definitions » Research & Development

VRNOF (Verano Holdings) Research & Development : $0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Verano Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Verano Holdings's Research & Development for the three months ended in Sep. 2024 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $0.0 Mil.

Verano Holdings Research & Development Historical Data

The historical data trend for Verano Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verano Holdings Research & Development Chart

Verano Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
- - - - -

Verano Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Verano Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Verano Holdings  (OTCPK:VRNOF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Verano Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Verano Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Verano Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Verano Holdings Corp (OTCPK:VRNOF) » Definitions » Research & Development
Comparable Companies
XCNQ:TRUL TSX:CRON TSX:TSND XCNQ:CL TSX:DHT.U TSX:WEED TSX:GUD XCNQ:GTII NEOE:GLAS.A.U XCNQ:AAWH.U ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
76U0:Germany VRNO:Canada
Address
214 West Hill Street, Suite 400, Chicago, IL, USA, 60610
Website
https://www.veranogrown.com
Verano Holdings Corp is a vertically integrated multi?state cannabis operator in the United States. The Company has two reportable segments: (i) cultivation (wholesale) and (ii) retail. The company's consumer brands include Encore, Avexia, MÜV, Savvy, BITS and Verano. The company's retail dispensaries operate under brands including Zen Leaf and MÜV. The company derives its revenues from Retail segment.